Literature DB >> 17617849

Japanese encephalitis for a reference to international travelers.

Akira Oya1, Ichiro Kurane.   

Abstract

Japanese encephalitis (JE) is an inflammatory disease in the central nervous system caused by infection with Japanese encephalitis virus (JEV). JE is a disease with a high fatality rate and endemic and epidemic in East, Southeast, and South Asia. High morbidity is noted in children living in the endemic area. JEV is maintained mainly between vector mosquitoes and pigs in nature. The risk of JE increases as the number of vector mosquitoes increases. The expansion of JEV-endemic area depends on irrigated rice field and pig farming. These environments that are suitable for infectious cycle of JEV exist widely in Asia today. The effective and safe vaccine is available in endemic countries and for international travelers. JE vaccination is strongly recommended to those who visit the JEV-endemic regions, especially in the rainy season.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17617849     DOI: 10.1111/j.1708-8305.2007.00134.x

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  18 in total

1.  Japanese encephalitis in a French traveler to Nepal.

Authors:  S Lagarde; J-C Lagier; R Charrel; G Quérat; J Vanhomwegen; P Desprès; J Pelletier; E Kaphan
Journal:  J Neurovirol       Date:  2014-01-10       Impact factor: 2.643

2.  Phase III clinical trials comparing the immunogenicity and safety of the vero cell-derived Japanese encephalitis vaccine Encevac with those of mouse brain-derived vaccine by using the Beijing-1 strain.

Authors:  Chiaki Miyazaki; Kenji Okada; Takao Ozaki; Mizuo Hirose; Kaneshige Iribe; Hiroyuki Yokote; Yuji Ishikawa; Takehiro Togashi; Kohji Ueda
Journal:  Clin Vaccine Immunol       Date:  2013-12-11

3.  TNF-alpha-dependent regulation of CXCR3 expression modulates neuronal survival during West Nile virus encephalitis.

Authors:  Bo Zhang; Jigisha Patel; Michelle Croyle; Michael S Diamond; Robyn S Klein
Journal:  J Neuroimmunol       Date:  2010-06-25       Impact factor: 3.478

4.  Evaluation of extracellular subviral particles of dengue virus type 2 and Japanese encephalitis virus produced by Spodoptera frugiperda cells for use as vaccine and diagnostic antigens.

Authors:  Miwa Kuwahara; Eiji Konishi
Journal:  Clin Vaccine Immunol       Date:  2010-07-28

5.  Bioinformatics in new generation flavivirus vaccines.

Authors:  Penelope Koraka; Byron E E Martina; Albert D M E Osterhaus
Journal:  J Biomed Biotechnol       Date:  2010-05-10

6.  Seroprevalence of Japanese encephalitis virus infection in captive Japanese macaques (Macaca fuscata).

Authors:  Hiroshi Shimoda; Akatsuki Saito; Keita Noguchi; Yutaka Terada; Ryusei Kuwata; Hirofumi Akari; Tomohiko Takasaki; Ken Maeda
Journal:  Primates       Date:  2014-04-19       Impact factor: 2.163

Review 7.  Japanese encephalitis and vaccines: past and future prospects.

Authors:  Maria Paulke-Korinek; Herwig Kollaritsch
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

8.  Evaluation of serological diagnostic test systems assessing the immune response to Japanese encephalitis vaccination.

Authors:  Nadine Litzba; Christoph S Klade; Sabine Lederer; Matthias Niedrig
Journal:  PLoS Negl Trop Dis       Date:  2010-11-16

9.  Development and characterization of the replicon system of Japanese encephalitis live vaccine virus SA14-14-2.

Authors:  Shi-Hua Li; Xiao-Feng Li; Hui Zhao; Yong-Qiang Deng; Xue-Dong Yu; Shun-Ya Zhu; Tao Jiang; Qing Ye; E-De Qin; Cheng-Feng Qin
Journal:  Virol J       Date:  2013-02-26       Impact factor: 4.099

10.  Central nervous system infections in travelers.

Authors:  H L Kirsch; K T Thakur; G L Birbeck
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.663

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.